← Full daily brief

Mass Tort brief

Mass Tort Brief: Medtronic Bellwether Verdict and UK Group Action Precedents

US jury orders Medtronic to pay $88M in hernia mesh trial as UK courts refine binding rules for group litigation and collective actions.

Signalpoint TeamBrief

Mass Tort

Medtronic lost an $88M hernia mesh bellwether trial — adverse jury verdicts increase settlement pressure across 10,000 pending claims.

BackgroundBellwether trials serve as test cases in multi-district litigation to gauge jury reactions and help parties evaluate settlement ranges. Over 10,000 similar surgical mesh claims remain pending against Medtronic, a key NHS device supplier.

Points
  1. The jury awarded $77 million in compensatory damages to patient Larry Patterson and $11 million to his spouse, establishing a high benchmark for future cases.
  2. Plaintiffs demonstrated that the resorbable collagen barrier degraded in seven days rather than the advertised 30 days, causing widespread internal scarring.
  3. Medtronic is a primary surgical device supplier to the NHS, where regulatory scrutiny over mesh implants remains intense following UK safety reviews.

Mass Tort

The Supreme Court clarified GLO group litigation rules — trial judges gain flexibility when precedent shifts during group suits.

BackgroundGroup Litigation Orders manage multiple opt-in claims sharing common legal issues across courts in England and Wales. Rulings on designated test issues usually bind all registered claimants automatically.

Points
  1. The Supreme Court ruled in Axa Insurance v HMRC regarding CPR 19.23 procedural binding mechanisms, establishing clear exceptions for group registers.
  2. Judges retain explicit discretion to grant relief from test case rulings if subsequent legal developments create obvious injustice across group registers.
  3. The precedent directly impacts active UK group actions, giving claimants in long-running environmental and financial mis-selling suits room to adjust strategy.

Mass Tort

The CAT approved a drop-hands settlement in the £480M Which? suit — tribunals are tightening scrutiny on unviable class actions.

BackgroundThe Competition Appeal Tribunal hears opt-out collective proceedings brought under the Consumer Rights Act 2015. Drop-hands settlements resolve ongoing litigation with neither party paying financial compensation to the other.

Points
  1. The £480 million opt-out claim was brought on behalf of 29 million UK smartphone owners targeting Qualcomm's patent licensing practices.
  2. Following a five-week trial, the Tribunal assessed the claim's likelihood of ultimate success at under 10%, justifying the zero-payout exit.
  3. The approval sets a critical precedent that increases judicial scrutiny over unviable opt-out claims and speculative litigation funding arrangements.

Unlock the full brief

Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.